25(OH)D3 and 1.25(OH)2D3 inhibits TNF-α expression in human monocyte derived macrophages. by Aisha Rafique, Lars Rejnmark, Lene Heickendorff, Holger Jon Møller

Get full text

A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice by Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen, Mie Hessellund Samson, Holger Jon Møller

Get full text

Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass by Konstantin Kazankov, Kirstine Nyvold Bojsen‐Møller, Holger Jon Møller, Sten Madsbad, Henning Grønbæk

Get full text

Systemic, but not local, low-grade endotoxinemia increases plasma sCD163 independently of the cortisol response by Ermina Bach, Niels Møller, Jens Otto L Jørgensen, Mads Buhl, Holger Jon Møller

Get full text

Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosis. by Morten Stilund, Ann-Kathrin Reuschlein, Tove Christensen, Holger Jon Møller, Peter Vestergaard Rasmussen, Thor Petersen

Get full text

Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure by Marlene Christina Nielsen, Rasmus Hvidbjerg Gantzel, Joan Clària, Jonel Trebicka, Holger Jon Møller, Henning Grønbæk

Get full text

Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients by Ninna Aggerholm-Pedersen, Henriette Nymark Friis, Thomas Baad-Hansen, Holger Jon Møller, Birgitte Sandfeld-Paulsen

Get full text

High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study by Jessica Björklund, Tea Lund Laursen, Thomas Damgaard Sandahl, Holger Jon Møller, Hendrik Vilstrup, Peter Ott, Henning Grønbæk

Get full text

Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis. by Emilie Glavind, Niels Kristian Aagaard, Henning Grønbæk, Holger Jon Møller, Nikolaj Worm Orntoft, Hendrik Vilstrup, Karen Louise Thomsen

Get full text

The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial by Nina Kimer, Mads Meldgaard, Ole Hamberg, Thit Mynster Kronborg, Allan M. Lund, Holger Jon Møller, Flemming Bendtsen, Henriette Ytting

Get full text

The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial. by Nina Kimer, Mads Meldgaard, Ole Hamberg, Thit Mynster Kronborg, Allan M Lund, Holger Jon Møller, Flemming Bendtsen, Henriette Ytting

Get full text

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis by Rasmus Hvidbjerg Gantzel, Mikkel Breinholt Kjær, Tea Lund Laursen, Konstantin Kazankov, Konstantin Kazankov, Jacob George, Holger Jon Møller, Henning Grønbæk

Get full text

The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients. by Thomas Damgaard Sandahl, Sidsel Hyldgaard Støy, Tea Lund Laursen, Sidsel Rødgaard-Hansen, Holger Jon Møller, Søren Møller, Hendrik Vilstrup, Henning Grønbæk

Get full text

No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled t... by Nina Kimer, Natasja Stæhr Gudmann, Julie Steen Pedersen, Søren Møller, Mette Juul Nielsen, Diana Julie Leeming, Morten Asser Karsdal, Holger Jon Møller, Flemming Bendtsen, Henning Grønbæk

Get full text

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension by Nikolaj Worm Ørntoft, Michel Blé, Anna Baiges, Jose Ferrusquia, Virginia Hernández-Gea, Fanny Turon, Marta Magaz, Søren Møller, Holger Jon Møller, Juan Carlos Garcia-Pagan, Henning Gronbaek

Get full text

Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2... by Rahim Mohammad Naimi, Mark Hvistendahl, Nikolaj Nerup, Rikard Ambrus, Michael Patrick Achiam, Lars Bo Svendsen, Henning Grønbæk, Holger Jon Møller, Hendrik Vilstrup, Adam Steensberg, Palle Bekker Jeppesen

Get full text

Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease by Konstantin Kazankov, Konstantin Kazankov, Chiara Rosso, Ramy Younes, Angelo Armandi, Hannes Hagström, Hannes Hagström, Hannes Hagström, Holger Jon Møller, Per Stål, Per Stål, Elisabetta Bugianesi, Henning Grønbæk

Get full text

Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020 by Kathrine Agergård Kaspersen, Thomas Greve, Kent Jacob Nielsen, Sanne Jespersen, Susan Mikkelsen, Jesper Medom Vestergaard, Jacob Dvinge Redder, Martin Tolstrup, Marianne Kragh Thomsen, Holger Jon Møller, Lars Østergaard, Henrik Albert Kolstad, Christian Erikstrup

Get full text

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease by Emilie Glavind, Daniel N. Gotthardt, Jan Pfeiffenberger, Thomas Damgaard Sandahl, Teodora Bashlekova, Gro Linno Willemoe, Jane Preuss Hasselby, Karl Heinz Weiss, Holger Jon Møller, Hendrik Vilstrup, William M. Lee, Michael L. Schilsky, Peter Ott, Henning Grønbæk

Get full text